Antioxidant enzyme activities and oxidative stress in affective disorders.
about
Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorderOxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant ApproachesPsychiatric Disorders and Polyphenols: Can They Be Helpful in Therapy?Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidenceEvidence of toxicity, oxidative stress, and neuronal insult in autismRestorative biological processes and healthIncreased risk of nonalcoholic fatty liver disease with occupational stress in Chinese policemen: A 4-year cohort studyLeukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress--preliminary findingsEffect of St. John's Wort (Hypericum perforatum) treatment on restraint stress-induced behavioral and biochemical alteration in miceOxidative stress in early stage Bipolar Disorder and the association with response to lithiumReduced antioxidant defense in early onset first-episode psychosis: a case-control study.Associations between the antioxidant network and emotional intelligence: a preliminary studyA urinary marker of oxidative stress covaries positively with hostility among midlife community volunteers.Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients.New evidence on iron, copper accumulation and zinc depletion and its correlation with DNA integrity in aging human brain regions.A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures.Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorderIgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) than in major depression.Clinical implications of lipid peroxidation in acne vulgaris: old wine in new bottles.The impact of GPX1 on the association of groundwater selenium and depression: a Project FRONTIER studyOxidative stress in older patients with bipolar disorder.Depression and oxidative stress: results from a meta-analysis of observational studies.Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania.Depression-like effect of prenatal buprenorphine exposure in rats.Analysis of manganese superoxide dismutase (MnSOD: Ala-9Val) and glutathione peroxidase (GSH-Px: Pro 197 Leu) gene polymorphisms in mood disorders.The Role of Nutrients in Protecting Mitochondrial Function and Neurotransmitter Signaling: Implications for the Treatment of Depression, PTSD, and Suicidal Behaviors.Markers of Oxidative Stress and Neuroprogression in Depression Disorder.Review of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesisEffect of consuming a grape seed supplement with abundant phenolic compounds on the oxidative status of healthy human volunteersBiobehavioral and neuroendocrine correlates of antioxidant enzyme activity in ovarian carcinoma.Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profilePsychotropic effects of antimicrobials and immune modulation by psychotropics: implications for neuroimmune disordersEfficacy of vitamin C as an adjunct to fluoxetine therapy in pediatric major depressive disorder: a randomized, double-blind, placebo-controlled pilot study.Increased oxidative stress in patients with depression and its relationship to treatment.Antioxidants as potential therapeutics for neuropsychiatric disorders.Independent and co-morbid HIV infection and Meth use disorders on oxidative stress markers in the cerebrospinal fluid and depressive symptoms.Defects of mitochondrial electron transport chain in bipolar disorder: implications for mood-stabilizing treatment.Novel therapeutic targets in depression and anxiety: antioxidants as a candidate treatment.New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects.
P2860
Q24651240-B7539CDD-EDEF-49D5-A115-92F6B7C91217Q26738789-BE60BF60-ED3F-43C0-A963-8C04FD971428Q26800960-18AE54A0-B3B9-4147-B1BB-71CDD3CFDE0DQ26999061-E8BA75DD-03F6-4140-8FEA-6C4AC3D1DF56Q28272947-E3F833CC-8EC4-4688-91AF-3E466A609571Q28391891-BA4E6A90-F50C-485B-AF48-3844CDBA769EQ28394768-0D412EFE-633B-4CEA-8423-9BD0F1E96E6DQ28741691-B2D7EF13-4D82-482C-818B-82E6B161AFB5Q33575153-2DCB69B1-B009-42B7-A0CD-F19EDB2D9612Q33738259-367FBA9E-01CB-4064-894A-F5D370559704Q33820188-73E68219-10AE-4D1C-A37F-F4F086CEA9B1Q33830862-84B7E93F-8A99-4B31-A459-1191FB57DF1EQ33906780-BA85FD44-6677-4DD5-8F15-D7C1D21B1931Q33979025-92A6225D-4DD3-43FC-BF47-AF082B2D92BAQ34082641-6DD36804-2D6F-4DE7-9D89-278DE5A4AD00Q34238394-4BAF96D1-6D32-4F7B-AC63-F259EAAB169EQ34268156-5732C61F-10A3-4935-BB70-031FEAC05F25Q34276668-F71768C1-3493-4408-956F-88557006CD12Q34447995-5BE20A2C-D21F-4159-8094-E0879724F8E6Q34536698-350FEE18-8A03-45C8-BC5A-E80BFDA25A10Q34585536-53273C85-6B46-48FB-9CAE-07B7CDC39B1EQ34909285-EA1D72B9-04A5-42F3-9AC7-073C411C04AFQ35012652-C0D439D1-C5A8-4A5B-BA16-DD01A6570DD3Q35075284-9133B25B-2229-484B-BE1E-B605CFE89298Q35099770-D52045A0-1AE0-4C07-B158-E7A862D5E6F1Q35563633-138338C7-6410-42EB-9E33-1584A9235839Q35677056-07F50D11-53D8-4261-90B8-9E6E3F9DD221Q35962076-A6B7E990-BC8C-4615-A0B8-F65F09A502F3Q36040894-41D453F6-8813-4CAA-BD24-09F1218E03D4Q36244900-A9C0ADE3-28C0-41D1-A4D5-3166F50A9350Q36246448-6CDC48F8-B7A3-4F8D-AF69-43A837BDC3EFQ36387362-994BAF28-CC15-4305-9CC7-72E455AD4663Q36690533-532405E9-AF7F-48DE-8BC0-4845D9ED3AEDQ36736022-0ADB3877-58D9-4FC4-BFC9-B671DA11C502Q36736055-6AB8AF97-811D-470A-BCB2-1A47C348FDAEQ36988191-D7D3ACC2-8776-4E79-815B-851FDB6B9310Q37054253-08956BC2-74C8-4ABE-83A9-DC03196589D9Q37661357-F04B6CA4-38C4-4C1E-8646-5E37E45A406BQ37978196-C87B26E4-95C1-4EC0-B58D-1F9A51F965FFQ38049302-33296BCF-64FB-4764-806F-6349F143691B
P2860
Antioxidant enzyme activities and oxidative stress in affective disorders.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Antioxidant enzyme activities and oxidative stress in affective disorders.
@en
Antioxidant enzyme activities and oxidative stress in affective disorders.
@nl
type
label
Antioxidant enzyme activities and oxidative stress in affective disorders.
@en
Antioxidant enzyme activities and oxidative stress in affective disorders.
@nl
prefLabel
Antioxidant enzyme activities and oxidative stress in affective disorders.
@en
Antioxidant enzyme activities and oxidative stress in affective disorders.
@nl
P2093
P1476
Antioxidant enzyme activities and oxidative stress in affective disorders.
@en
P2093
Elif Ozerol
M Erkan Ozcan
Mukaddes Gulec
Omer Akyol
Ruhcan Polat
P356
10.1097/00004850-200403000-00006
P577
2004-03-01T00:00:00Z